Therefore, population-specific factors should be considered in clinical applications
Twenty-four hours heart rate was measured in the respiratory chamber using a heart rate monitoring system (Polar Electro Oy, Kempele, Finland) with 1-min intervals
5.5 Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin The risk of hypoglycemia is increased when OZEMPIC is used in combination with insulin secretagogues (e.g., sulfonylureas) or insulin
Enzymatic Sensitivity Experiments: Supports investigations into enzyme activation thresholds, substrate binding, and catalytic efficiency under peptide-modulated conditions
No New Drug Application (NDA) or Biologics License Application (BLA) for BPC-157 has been submitted or approved by the agency
Normal Reactions: You may notice a mild greenish discoloration of urine or stool, indicating that the detoxification process is working